Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/1998
03/05/1998WO1998009159A1 Micro injector sample delivery system for charged molecules
03/05/1998WO1998008974A2 Catalytic nucleic acid and its medical use
03/05/1998WO1998008973A1 Global amplification of nucleic acids
03/05/1998WO1998008972A1 Sequential hybridization of fungal cell dna and method for the detection of fungal cells in clinical material
03/05/1998WO1998008971A1 Method to detect clinically relevant mutations of the dna sequence of ki -ras oncogene, its use and a testkit for early diagnosis of tumours
03/05/1998WO1998008965A2 Cd95 regulatory gene sequences and transcription factors
03/05/1998WO1998008964A1 Mammalian artificial chromosomes
03/05/1998WO1998008963A1 Gene combinations for herbicide tolerance in corn
03/05/1998WO1998008962A1 Early seed 5' regulatory sequence
03/05/1998WO1998008961A2 Endosperm and nucellus specific genes, promoters and uses thereof
03/05/1998WO1998008960A1 IDENTIFICATION OF AND CLONING A MOBILE TRANSPOSON FROM $i(ASPERGILLUS)
03/05/1998WO1998008959A1 In vivo protein synthesis method
03/05/1998WO1998008958A1 Novel expression vectors
03/05/1998WO1998008957A1 Compositions and methods for specifically targeting tumors
03/05/1998WO1998008956A2 Use of a mutated macrolide binding protein for the prevention of gvhd
03/05/1998WO1998008955A1 Stimulus-inducible i (kappa)b kinase [ikk] signalsome
03/05/1998WO1998008954A2 Production of heme and recombinant hemoproteins
03/05/1998WO1998008953A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods
03/05/1998WO1998008952A1 Vaccine production of the bacillus anthracis protective antigen
03/05/1998WO1998008951A1 New brucella antigens, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits
03/05/1998WO1998008950A1 Novel monocyte activating cytokine
03/05/1998WO1998008949A1 P-selectin ligand proteins
03/05/1998WO1998008948A1 Protein targeting to glycogen
03/05/1998WO1998008947A1 Enhancement of dna immunization through the use of cytokines
03/05/1998WO1998008946A1 Antigens derived from filaggrin and their use for diagnosing rheumatoid polyarthritis
03/05/1998WO1998008945A1 Protein inhibitor of neuronal nitric oxide synthase
03/05/1998WO1998008944A1 Novel bacteriophage, method for screening the same, novel biobactericidal materials prepared with the use of the same, and reagent for detecting the same
03/05/1998WO1998008943A1 Hla-drb1 peptides with specific binding affinity for hla-dq molecules: prevention and treatment of rheumatoid arthritis
03/05/1998WO1998008937A1 Method for sorting antifungal molecules acting on the glucanosyltransferase activity
03/05/1998WO1998008936A1 Recombinant canine herpesvirus
03/05/1998WO1998008934A1 Serum-free mammalian cell culture medium, and uses thereof
03/05/1998WO1998008933A1 Kuz, a novel family of metalloproteases
03/05/1998WO1998008874A1 Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
03/05/1998WO1998008872A1 Glp-2 derivatives
03/05/1998WO1998008870A1 Interleukin-19
03/05/1998WO1998008869A1 Hematopoietic stem cell growth factor (scgf)
03/05/1998WO1998008864A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
03/05/1998WO1998008863A1 Enzyme and dna sequence encoding same
03/05/1998WO1998008859A1 Bioconjugates and delivery of bioactive agents
03/05/1998WO1998008856A2 Mirror-symmetrical selection and evolution of nucleic acids
03/05/1998WO1998008607A1 Altering dough viscoelasticity with modified glutenins
03/05/1998WO1998008542A2 Compounds and methods for treatment and diagnosis of mycobacterial infections
03/05/1998WO1998008388A1 Pesticidal agents
03/05/1998WO1998008381A1 Therapeutic and diagnostic applications of perlecan domain i splice variants
03/05/1998WO1998008375A1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid
03/05/1998WO1998004717A3 Double-stranded rna dependent protein kinase derived peptides to promote proliferation of cells and tissues in a controlled manner
03/05/1998WO1998004586A3 Polynucleotide and its use for modulating a defence response in plants
03/05/1998WO1998002552A3 Vaccine compositions
03/05/1998WO1998002548A3 Infectious papillomavirus pseudoviral particles
03/05/1998WO1998001554A3 Secreted proteins and polynucleotides encoding them
03/05/1998WO1998001553A3 Secreted proteins and polynucleotides encoding them
03/05/1998WO1998001552A3 Secreted proteins and polynucleotides encoding them
03/05/1998WO1998001160A3 Compositions suitable for delivery of genes to epithelial cells
03/05/1998WO1998000532A3 Oligonucleotides from the untranslated regions of ribonucleotide reductase and their use to modulate cell growth
03/05/1998WO1997044474A3 Viral particles which are masked or unmasked with respect to a cell receptor
03/05/1998WO1997040462A3 Correlating polymorphic forms with multiple phenotypes
03/05/1998WO1997033615A3 Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection
03/05/1998DE19737917A1 Detection of Ki-ras oncogene alterations
03/05/1998CA2265088A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods
03/05/1998CA2264576A1 Protein inhibitor of neuronal nitric oxide synthase
03/05/1998CA2264571A1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid
03/05/1998CA2264550A1 In vivo protein synthesis method
03/05/1998CA2264548A1 Interleukin-19
03/05/1998CA2264246A1 Catalytic nucleic acid and its medical use
03/05/1998CA2264244A1 Vaccine production of the bacillus anthracis protective antigen
03/05/1998CA2263951A1 Use of a mutated macrolide binding protein for the prevention of gvhd
03/05/1998CA2263897A1 Pesticidal agents
03/05/1998CA2263885A1 Compounds and methods for treatment and diagnosis of mycobacterial infections
03/05/1998CA2263827A1 Fibroblast growth factor homologous factors (fhfs) and methods of use
03/05/1998CA2263824A1 Cd95 regulatory gene sequences and transcription factors
03/05/1998CA2263819A1 Insecticidal protein toxins from photorhabdus
03/05/1998CA2263791A1 New brucella antigens, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits
03/05/1998CA2262519A1 Identification of and cloning a mobile transposon from aspergillus
03/05/1998CA2259151A1 Enzyme and dna sequence encoding same
03/05/1998CA2235867A1 Hematopoietic stem cell growth factor (scgf)
03/05/1998CA2233228A1 Global amplification of nucleic acids
03/05/1998CA2194256A1 Ikaros: a t cell pathway regulatory gene
03/05/1998CA2184780A1 Methods of diagnosing and treating cancer
03/04/1998EP0826780A1 Detection of nucleic acids using G-quartets
03/04/1998EP0826779A1 Strand displacement amplification using boronated nucleotides
03/04/1998EP0826775A1 Vector system for conditional gene expression
03/04/1998EP0826774A2 Staphylococcal Fab I enoyl-ACP reductase
03/04/1998EP0826773A2 Process for producing trans-4-hydroxy-l-proline
03/04/1998EP0826772A2 Human mucin (MUC8)
03/04/1998EP0826696A1 Use of bi-and trispecific antibodies for inducing tumor immunity
03/04/1998EP0826695A1 Destruction of contaminating tumor cells in stem cell transplants by use of bispecific antibodies
03/04/1998EP0826068A1 Method for diagnosing schizophrenia
03/04/1998EP0826066A1 Methods and reagents for combined pcr amplification and hybridization probing assay
03/04/1998EP0826064A1 Low oxygen affinity mutant hemoglobin
03/04/1998EP0826063A1 Single-vial formulations of dna/lipid complexes
03/04/1998EP0826062A1 Hbv vectors and cells for producing the same
03/04/1998EP0826061A2 Improvements in or relating to plant starch composition
03/04/1998EP0826060A2 Embedded expression of heterologous proteins
03/04/1998EP0826059A1 Apparatus and method for delivering a nucleotide into cell nuclei
03/04/1998EP0826058A2 Chimeric mcp and daf proteins with cell surface localizing domain
03/04/1998EP0826057A1 Bioconversion of a fermentable carbon source to 1,3-propanediol by a single microorganism
03/04/1998EP0826056A2 Stable variant hk2 polypeptide
03/04/1998EP0826055A1 New cathepsin c homolog
03/04/1998EP0826054A1 Expression of glycosyltransferase in aspergillus
03/04/1998EP0826053A1 H. INFLUENZAE HxuB AND HxuC GENES, PROTEINS AND METHODS OF USE